Fastomics: Metabolic and Therapeutic Effects of Prolonged Fasting
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorUniversity of Minnesota
About this trial
This is an observational study investigating how the metabolic and cell marker changes in Prolonged Fasting in the serum may be used against a cell-based model of disease for therapeutic purposes.
Eligibility criteria
Qualifiers
Ages of 18-65 years old
Not pregnant
No comorbid conditions
BMI of 18.5-29.9.
Disqualifiers
Concern for active eating disorder per screening questionnaire
Self-reported eating disorder or history of eating disorder
History of hypoglycemia or contraindication for Prolonged Fasting
Weight <120lbs
Trial design
Treatments tested in this trial
- Fasting
Treatment groups
15 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov